ADJUTEC PHARMA
AdjuTec Pharma specializes in developing antibiotic resistance breakers for the global market. Its core technology is a synthesis of β-lactamase inhibitors (BLIs) that inactivates bacteria resistance enzymes.
ADJUTEC PHARMA
Industry:
Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.adjutecpharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro VARITI
Similar Organizations
A-Pharmaconsult
A-pharmaconsult specializes in regulatory affairs, quality assurance, and product safety services for the healthcare industry.
Ai-biopharma
Ai-biopharma specializes in medicinal chemistry research for preclinical drug candidates.
Avipero
Avipero specializes in the development of allosteric modulators of integrins for triple-negative breast cancer.
Built by Doctors
Built by Doctors specializes in developing medical support guides for pharmaceutical companies.
Carelide Laboratory
Carelide Laboratory specializes in producing medications and single-use medical device for hospital.
plural+udifar
plural+udifar specializes in supplying, storing, and distributing medicines to their coworkers.
RxMM Health
RxMM Health specializes in advanced hydroponic cultivation of medical cannabis for the international market.
Wörwag Pharma
Wörwag Pharma specializes in the development of biofactors products and solutions that help to prevent and treat lifestyle diseases​.
Investors List
Farvatn Venture
Farvatn Venture investment in Seed Round - AdjuTec Pharma
Official Site Inspections
http://www.adjutecpharma.com
- Host name: 185.203.72.17
- IP address: 185.203.72.17
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "AdjuTec Pharma"
Adjutec Pharma AS
Norwegian pharmaceutical start-up company with innovative breakthrough which will help to save thousands of lives affected by antibiotic resistant infections.See details»
About Our Company - adjutecpharma.com
AdjuTec Pharma AS is a Norwegian pharmaceutical start-up company that was founded in 2019 based on research in antibiotic products at the University of Oslo (UoO), Norway. The …See details»
AdjuTec Pharma - Crunchbase Company Profile
Contact Email [email protected] AdjuTec Pharma specializes in developing antibiotic resistance breakers for the global market. Its core …See details»
Corporate Governance - Adjutec Pharma
At AdjuTec, we believe that having good rules for how we run our business is crucial for building trust, creating lasting value, and getting support for our projects.See details»
AdjuTec Pharma AS - Drug pipelines, Patents, Clinical …
Adjutecpharma.com. Holding Company | 2019 | Norway | < 10 | adjutecpharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) ... The statistics for drugs …See details»
AdjuTec Pharma AS | LinkedIn
AdjuTec Pharma AS is a Norwegian pharmaceutical start-up company that was founded in 2019 based on research in antibiotic products at the University of Oslo (UoO), Norway.See details»
AdjuTec Pharma AS - VentureRadar
"AdjuTec Pharma AS is a Norwegian pharmaceutical start-up company that was founded in 2019 based on research in antibiotic products at the University of Oslo (UoO), Norway.See details»
AdjuTec Pharma AS - VentureRadar
Website: https://www.adjutecpharma.com/ Develops novel antibiotic resistance breakers based on research from the University of Oslo, aiming to tackle antimicrobial ...See details»
AdjuTec Pharma AS Overview | SignalHire Company Profile
Organization Website: adjutecpharma.com : AdjuTec Pharma AS industries Pharma: Headquarters Location: St Olavs plass 5, Oslo, 0165 NO St Olavs plass 5, Oslo, 016...See details»
AdjuTec Pharma Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for AdjuTec Pharma. Use the PitchBook Platform to explore the full profile.See details»
AdjuTec Pharma (company) | Nordic 9
Adjutecpharma.com . See something wrong or missing? Let us know. Offices: Oslo. Industry: Health services Manufacturing Pharma. Business model: B2B. AdjuTec Pharma is a pharma …See details»
Investors - Adjutec Pharma
AdjuTec is entering a high-growth, global market. The global β-lactam and β-lactamase inhibitors market size was €22 billion in 2018, and is projected to reach €28 billion by 2028, growing at a …See details»
AdjuTec Pharma attracts public funding to optimize manufacturing
Jan 30, 2023 Just before Christmas, the Norwegian company announced that it has received support from Oslo County of 1.950 million NOK. The funding will support optimization of the …See details»
Adjutec Pharma - Products, Competitors, Financials, Employees ...
Adjutec Pharma focuses on developing novel resistance breakers as a new line of antibiotic defense. Use the CB Insights Platform to explore Adjutec Pharma's full profile.See details»
Contacts - Adjutec Pharma
Stay in touch with usSee details»
Adjutec Pharma - NOME
Adjutec Pharma Adjutec Pharma’s vision is to develop and provide novel antibiotic resistance breakers in order to retain efficacy and facilitate reduced use of antibiotics. Its lead products …See details»
AdjuTec Pharma AS’ Post - LinkedIn
🚀 Exciting News from AdjuTec Pharma! 🚀 We are thrilled to share that AdjuTec has received a positive response from the Norwegian Research Council (NRC), who has generously offered …See details»
AdjuTec Pharma AS’ Post - LinkedIn
🚀 Exciting News from AdjuTec Pharma! 🌟 We're thrilled to announce that we've reallocated all of our Eurostars #grant to our lead project, APC148 #research…See details»
News - adjutecpharma.com
Follow our latest news. BioStock Life Science Spring Summit is one of the Nordic region’s most important digital events showcasing the great breadth and level of innovation the Nordic life …See details»
R&D - adjutecpharma.com
In 2019, 1.3 million people died from antibiotic resistant infections, by 2050 as many as 10 million deaths are forecast if the situation is not changed. AdjuTec addresses this global problem by …See details»